首页> Future oncology (London, England)> Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma.

Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma.

导出原文传递

翻译打印收藏纠错

第一作者： Martin,Metzenmacher

第一单位： Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, Essen 45122, Germany.

作者： Martin,Metzenmacher ^[1] ; Filippo,Rizzo ^[2] ; Kato,Kambartel ^[3] ; Jens,Panse ^[4] ; Diana,Schaufler ^[5] ; Matthias,Scheffler ^[5] ; Ivo,Azeh ^[6] ; Mathias,Hoiczyk ^[7] ; Amin T,Turki ^[8] ; Judith,Atz ^[9] ; Hannes,Buchner ^[10] ; Christopher,Hoffmann ^[9] ; Daniel,C Christoph ^[2]

作者单位： Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, Essen 45122, Germany. ^[1] Department of Medical Oncology/Hematology, Evang, Kliniken Essen-Mitte, Essen, Germany. ^[2] Department of Pneumology & Allergy, Lung Cancer Center, Bethanien Hospital Moers, Germany. ^[3] Department of Oncology, Haematology, Haemostaseology & Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany. ^[4] University of Cologne, Faculty of Medicine & University Hospital of Cologne; Department I of Internal Medicine, Center for Integrated Oncology, Aachen Bonn Cologne Dusseldorf; Network Genomic Medicine, Lung Cancer Group Cologne, Cologne, Germany. ^[5] Onkologische Gemeinschaftspraxis und Tagesklinik, Gelsenkirchen, Germany. ^[6] Department of Gastroenterology, Hematology, Oncology, Diabetology & Rheumatology, Marien-Hospital Wesel, Pastor-Janßen-Straße 8-38, Wesel 46483, Germany. ^[7] Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, Essen 45122, Germany.;Department of Hematology & Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, Essen 45122, Germany. ^[8] Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany. ^[9] Staburo GmbH, Munich, Germany. ^[10]

关键词 advanced adenocarcinoma angiokinase inhibitor antiangiogenic therapy chemo-immunotherapy failure docetaxel nintedanib non-small-cell lung cancer (NSCLC)